A Path to Safer, More Effective Prescribing
Traditionally, medicine has relied on a trial and error approach to prescribing. Doctors use their best judgment based on research and experience to select the drug that should produce favorable results for their patients. During this process, patients may experience adverse drug reactions, some of which can be serious.
These reactions, also called ADRs, cost the U.S. $136 billion annually.1 They are the leading cause of hospitalization, and the fourth leading cause of death.2
Why continue paying for medications that aren’t effective and that patients cannot metabolize? BenePrecise removes guesswork from prescribing and gets straight to the medication that works.
75% – Up to 75% of patients derive NO benefit from their prescribed medication, depending on the therapeutic category.*
What is BenePrecise Pharmacogenetics?
BenePrecise examines differences in metabolism that occur at a genetic level and affect how the body processes certain medications. These metabolic pathways control whether a drug’s distribution in the bloodstream is too high, too low, or just right to provide the desired therapeutic benefit.
The application of pharmacogenetic data reduces adverse drug reactions, improves medication efficacy, and decreases the cost of healthcare. BeneCard PBF has some of the first pharmacogenetics-certified pharmacists in the nation, who work closely with patients, prescribers, and plan sponsors to find the best medication for the patient’s unique needs.
1 – Johnson JA, Bootman JL. “Drug-related morbidity and mortality. A cost-of-illness model.” Arch Intern Med 1995;155(18):1949–1956.
2 – Lazarou J, Pomeranz B, Corey PN. “Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies.” JAMA 1998;279:1200–1205.
* “Paving the Way for Personalized Medicine.” U.S. FDA